65,437 trials
Glaucoma
Primary: Mean Intraocular Pressure (IOP) Change at the Final Visit From Baseline (Prior Beta-blocker Monotherapy) — -5.0 millimeters mercury (mmHg)
Type 2 Diabetes Mellitus
Primary: Flow-mediated Dilation After Placebo or Acipimox Treatment Between Healthy Controls and Those With Metabolic Syndrome — 10.65; 11.57; 8.79; 9.52 Flow mediated dilation
Sleep Apnea, Obstructive
Primary: Change in AHI — 45; -15.8 events/h
Idiopathic Thrombocytopenic Purpura · Thrombocytopenia · Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Primary: Number of Participants With Splenectomy During 52-Week Treatment Period — 28; 14; 49; 143 Participants — p=<0.0001
Malaria · Malaria Vaccines
Primary: Concentrations of Antibodies Against Hepatitis B (Anti-HB) — 13.0; 14.3; 16.9; 111.8 milli-international unit per milliliter
Arthritis, Rheumatoid
Primary: Change From Baseline in the Volume Transfer Rate From the Blood Plasma to the Enhancing Synovium (Ktrans) — -0.2; 0.1 min ^-1 — p=<0.001
Diabetes
Primary: Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method — 84 Number of BG Test…
HIV Infections
Primary: Change in CSF Concentrations of Neopterin After 12 Weeks — 0.1; 0.3 nmol/L
Chronic Hepatitis C
Primary: Improvement in Viral Kinetics During the First 2 Weeks of Therapy — 14 participants
Crohn's Disease
Primary: Percentage of Subjects With at Least One Adverse Event (AE) During the Duration of This Study CDP870-034 (up to 84 Months) — 94.2 percentage of subjects
Post Traumatic Stress Disorder · Smoking · Anxiety
Primary: Change in PCL-M Score (PTSD Symptom Checklist-Military [PCL-M], Weathers et al., 1993) — -6.82456 units on a scale — p=.001
Papulopustular Rosacea
Primary: Nominal Change From Baseline in Inflammatory Lesion (IL) Count (Sum of Papules and Pustules) Per Participant at End of Study (LOCF: Last Observation Carried Forward)…
Adult Acute Basophilic Leukemia · Adult Acute Eosinophilic Leukemia · Adult Acute Megakaryoblastic Leukemia (M7)
Primary: Complete Response — 11 percentage of participants
Autistic Disorder
Primary: Clinical Global Impressions Scale — 3; 3 # participants much - very much improved — p=>.05
Non-Hodgkin's Lymphoma · Lymphoma, Large Cell · Diffuse, Mantle Cell Lymphoma, Lymphoma
Primary: The Overall Response Rate [Complete Response (CR) + Partial Response (PR)] Determined on the Basis of Revised Response Criteria for Malignant Lymphoma — 62.7 Percentage…